Clinical Trials on Acute Myeloid Leukemia With Maturation in Canada
Total 446 results
-
National Cancer Institute (NCI)TerminatedAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia in Remission | Adult Acute Monoblastic Leukemia | Adult Acute Monocytic Leukemia and other conditionsCanada
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Recurrent Adult Acute Myeloid Leukemia | Fungal Infection | Neutropenia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia in Remission | Childhood Acute Myeloid Leukemia in Remission | Recurrent Childhood Acute Myeloid... and other conditionsUnited States, Canada, Puerto Rico
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute Myeloblastic Leukemia Without Maturation (M1) | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities and other conditionsUnited States, Canada, Australia
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedSecondary Acute Myeloid Leukemia | Childhood Acute Erythroleukemia (M6) | Childhood Acute Megakaryocytic Leukemia (M7) | Childhood Acute Monoblastic Leukemia (M5a) | Childhood Acute Monocytic Leukemia (M5b) | Childhood Acute Myeloblastic Leukemia With Maturation (M2) | Childhood Acute Myeloblastic... and other conditionsUnited States, Canada, Australia, Puerto Rico
-
National Cancer Institute (NCI)TerminatedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) | Secondary Acute Myeloid Leukemia and other conditionsCanada
-
GlaxoSmithKlineTerminatedLeukaemia, Myelocytic, AcuteUnited States, Australia, Canada
-
Arog Pharmaceuticals, Inc.RecruitingRelapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating MutationsUnited States, Germany, Spain, Italy, France, Canada
-
Astellas Pharma Global Development, Inc.RecruitingAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)United States, Canada, Germany, Italy, Spain, United Kingdom, France
-
Astellas Pharma Global Development, Inc.Active, not recruitingAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) MutationUnited States, Japan, Taiwan, Spain, Australia, Belgium, Canada, France, Germany, Italy, Korea, Republic of, Poland, United Kingdom
-
University Health Network, TorontoMerck Sharp & Dohme LLCCompletedAcute Myeloid LeukemiaCanada
-
Hamilton Health Sciences CorporationUnknownLeukemia, Myeloid, AcuteCanada
-
Maisonneuve-Rosemont HospitalUnknown
-
University Health Network, TorontoCompleted
-
University Health Network, TorontoNovartis PharmaceuticalsTerminated
-
Novartis PharmaceuticalsNo longer availableFLT3-mutated Acute Myeloid LeukemiaCanada
-
Sarit AssoulineCompleted
-
University Health Network, TorontoCelgene CorporationCompleted
-
Synta Pharmaceuticals Corp.UnknownAcute Myeloid LeukemiaCanada
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedMyeloid Neoplasm | Childhood Acute Promyelocytic Leukemia With PML-RARAUnited States, Canada, Puerto Rico
-
PETHEMA FoundationCompletedAcute Myeloblastic LeukaemiaSpain
-
University Health Network, TorontoOzmosis Research Inc.Active, not recruitingAcute Myeloid LeukemiaCanada
-
Jewish General HospitalThe Leukemia and Lymphoma SocietyCompleted
-
Ontario Clinical Oncology Group (OCOG)Hamilton Health Sciences Corporation; Juravinski Cancer Centre FoundationCompleted
-
Astellas Pharma Global Development, Inc.CompletedAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) / Internal Tandem Duplication (ITD) MutationTaiwan, Poland, Serbia, United States, Brazil, Canada, Czechia, Denmark, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Portugal, Romania, Spain, Sweden, United Kingdom
-
University of AlbertaWithdrawnLeukemia, Myeloid, Acute | Leukemia, Myelomonocytic, Acute | Leukemia, Monocytic, Acute | Leukemia, Megakaryoblastic, Acute | Leukemia, Erythroblastic, AcuteCanada
-
National Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Disease | Recurrent Adult Acute Lymphoblastic Leukemia | Secondary Myelodysplastic Syndrome | de Novo Myelodysplastic... and other conditionsUnited States, Canada, New Zealand
-
University Health Network, TorontoMemorial Sloan Kettering Cancer Center; University of California, Los Angeles; University of KansasCompletedAcute Myeloid LeukemiaUnited States, Canada
-
Astellas Pharma Global Development, Inc.TerminatedAcute Myeloid LeukemiaUnited States, Canada
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAcute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARAUnited States, Canada, Saudi Arabia, Puerto Rico, Australia, New Zealand
-
University Health Network, TorontoCompletedAcute Myeloid LeukemiaCanada
-
Hoffmann-La RocheCompletedNeoplasms, Myelogenous Leukemia, AcuteUnited States, Canada
-
Genentech, Inc.Completed
-
Toronto Rehabilitation InstituteCompletedAcute Myeloid LeukemiaCanada
-
Karolinska InstitutetMedical University of Vienna; Oslo University Hospital; Sahlgrenska University... and other collaboratorsTerminatedAcute Myeloid LeukemiaCanada, Austria, Sweden, Russian Federation, Norway
-
Gemin XCompleted
-
Astellas Pharma Global Development, Inc.TerminatedAcute Myeloid LeukemiaCanada, United States
-
PETHEMA FoundationRecruiting
-
Jewish General HospitalThe Leukemia and Lymphoma SocietyCompletedAcute Myelocytic LeukemiaCanada
-
University Health Network, TorontoNational Cancer Institute (NCI)Completed
-
University Health Network, TorontoOzmosis Research Inc.RecruitingAcute Myeloid LeukemiaCanada
-
Centre de recherche du Centre hospitalier universitaire...WithdrawnAcute Myeloid LeukemiaCanada
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaCompletedAcute Myeloid LeukemiaCanada
-
AstraZenecaTerminatedAcute Myeloid LeukemiaUnited States, Canada
-
Hoffmann-La RocheTerminatedLeukemia, Myeloid, AcuteItaly, Korea, Republic of, Belgium, Australia, United States, Canada, United Kingdom, Spain, Netherlands, France, Germany, New Zealand, Israel, Norway, Russian Federation, Switzerland, Austria, Finland, Panama
-
CephalonTerminatedAcute Myeloid LeukemiaUnited States, Canada
-
AmgenTerminatedRelapsed/Refractory Acute Myeloid Leukemia (AML)United States, Korea, Republic of, Australia, Japan, Germany, Canada
-
Toronto Rehabilitation InstituteUniversity Health Network, Toronto; The Leukemia and Lymphoma SocietyCompletedQuality of Life | Acute Myeloid Leukemia | Fatigue | ExerciseCanada
-
Epizyme, Inc.Celgene CorporationCompletedAcute Myeloid Leukemia | Leukemia | Acute Lymphocytic Leukemia | Acute LeukemiasUnited States, Canada
-
PETHEMA FoundationCompleted
-
Actinium PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia | Leukemia, Myeloid, Acute | AML | Acute Myelogenous Leukemia | Bone Marrow Transplant | Myelogenous Leukemia, Acute | Myeloid Leukemia, Acute | Leukemia, Acute Myelogenous | Leukemia, Acute MyeloidUnited States, Canada